Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance
- 5 June 2009
- journal article
- review article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 30 (6) , 702-714
Abstract
A number of studies have confirmed the potential for neuronal nicotinic acetylcholine receptor (NNR)-mediated neuroprotection and, more recently, its anti-inflammatory effects. The mechanistic overlap between these pathways and the ubiquitous effects observed following diverse insults suggest that NNRs modulate fundamental pathways involved in cell survival. These results have wide-reaching implications for the design of experimental therapeutics that regulate inflammatory and anti-apoptotic responses through NNRs and represent an initial step toward understanding the benefits of novel therapeutic strategies for the management of central nervous system disorders that target neuronal survival and associated inflammatory processes.Keywords
This publication has 108 references indexed in Scilit:
- Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cellsJournal of Neurochemistry, 2008
- Loss of high‐affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environmentThe FASEB Journal, 2007
- Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligandsLife Sciences, 2007
- Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7Clinical and Experimental Immunology, 2006
- Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemiaBiochemical and Biophysical Research Communications, 2006
- Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsisJournal of Experimental Medicine, 2006
- Effect of Subchronic Treatment of Memantine, Galantamine, and Nicotine in the Brain of Tg2576 (APPswe) Transgenic MiceThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Stimulation of nicotinic acetylcholine receptors protects motor neuronsBiochemical and Biophysical Research Communications, 2005
- Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen–glucose deprivationNeuroscience Letters, 2004
- Regulation of the Neuronal Nicotinic Acetylcholine Receptor by Src Family Tyrosine KinasesJournal of Biological Chemistry, 2004